Center Quality Specialist 1
About the job
- A high school diploma, GED, or equivalent is required.
- Three to six months of quality or plasma industry experience is required as an alternative to an associate degree.
- Strong verbal and written communication skills are required.
- Above-average problem-solving and decision-making abilities are required.
- Proficiency with computers is required.
- Attention to detail, analytical skills, organization, and follow-up are required.
- Ability to read and interpret safety rules, operating and maintenance instructions, and procedural and technical manuals is required.
- Ability to interpret technical instructions in mathematical or diagram form and work with abstract and concrete variables is required.
- Ability to perform all phases of donor plasmapheresis is required.
- Ability to make and analyze physical assessments, including heart and lung sounds and signs of drug use, is required.
- Ability to stand for up to four hours at a time and lift, tug, or pull up to 50 pounds is required.
- Perform donor record file reviews.
- Perform daily, weekly, monthly, semi-annual, and annual equipment quality-control reviews.
- Review medical reports and communications.
- Review equipment incidents.
- Verify and release sample shipments.
- Inspect and release incoming supplies.
- Initiate deviation reports as needed.
- Perform weekly employee observations.
- Assist the Manager of Quality Assurance with compliance involving state and federal regulations, the FDA-approved Standard Operating Procedure Manual, Clinical Laboratory Improvement Amendments, Current Good Manufacturing Practice, Occupational Safety and Health Administration requirements, and internal company procedures.
- Review documentation of unsuitable test results and disposition associated units.
- In the absence of the Manager of Center Quality Assurance, conduct root-cause analyses for deviations and customer complaints related to donor safety and product quality.
- Review equipment records and donor system information to approve out-of-service equipment for use when applicable.
- Review and approve deferred donor reinstatement activities.
- Review lookback information.
- Review waste shipments.
- Initiate investigations and report supplies that do not meet quality specifications and requirements before use.
- Review medical incident reports and documentation.
- Use hands to handle or feel objects, tools, or controls; reach with hands and arms; and frequently lean, bend, stoop, crouch, and reach above the shoulders and below the knee.
- Stand for extended periods of up to four hours at a time.
- Lift, tug, and pull up to 50 pounds.
- An associate degree is preferred.
About the company
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Arras released first medicines in 2025, proving commercialization after heavy capital spending.
- LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
- France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.
What critics are saying
- EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
- LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
- A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.
What makes LFB unique
- French state-owned sole domestic plasma fractionator anchors national medicine supply.
- Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
- Europlasma and Amber Plasma give LFB 24 Central European collection centers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Remote Work Options
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Hybrid Work Options
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend
Stock Options
Company Equity
Conference Attendance Budget
Family Planning Benefits
Fertility Treatment Support
Professional Development Budget
Education allowance
Tuition Reimbursement
Growth & Insights and Company News
6 month growth
↑ 8%1 year growth
↑ 8%2 year growth
↑ 7%Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.